FDA approving Alzhemer snake oil to fleece taxpayers?

[MichaelMay]

It probably is, though. We need to move past the amyloid theory. We've already been through, what, 9 drugs that didn't work before this one?

My man TheVrolok knows what's up. There are other drugs that DO work at least intermittently and yet this holy grail that was long lost in a sea of "doesn't fucking work" is still being pursued.

 

[Ken g6]

It probably is, though. We need to move past the amyloid theory. We've already been through, what, 9 drugs that didn't work before this one?

I agree. I compare it with developing a drug to dissolve scabs in order to treat sepsis.

 

[MichaelMay]

I agree. I compare it with developing a drug to dissolve scabs in order to treat sepsis.

That is a really good comparison.

 

[hal2kilo]

Well, well, well... Seems one drug is all it takes. Be nice if they had the data to back up this stuff. I think I'll just order some non FDA approved penis pills instead.

This one drug threatens to tank Medicare's entire prescription drug model | Salon.com

 

[Lost_in_the_HTTP]

Pricing must have been crap to begin with, eh?

Biogen cuts Alzheimer's drug price 50 percent months after approval

The Boston Globe|17 minutes ago
The company will reduce the annual list price of the treatment to $28,200 to lower out-of-pocket costs for patients and reduce "the potential financial implications for the US health-care system."

 

[fskimospy]

Pricing must have been crap to begin with, eh?

Biogen cuts Alzheimer's drug price 50 percent months after approval

The Boston Globe|17 minutes ago
The company will reduce the annual list price of the treatment to $28,200 to lower out-of-pocket costs for patients and reduce "the potential financial implications for the US health-care system."

Oh good, only $28,000 a year for a drug that appears to be largely worthless.

This is your occasional reminder that Medicare is forbidden by law from considering the cost of a drug and so the 'potential financial implications' are essentially that Medicare is forced to pay for something everyone knows doesn't work (or doesn't work very well).

 

[TheVrolok]

Oh good, only $28,000 a year for a drug that appears to be largely worthless.

This is your occasional reminder that Medicare is forbidden by law from considering the cost of a drug and so the 'potential financial implications' are essentially that Medicare is forced to pay for something everyone knows doesn't work (or doesn't work very well).

Worse than worthless, dangerous.

 

[uallas5]

Worse than worthless, dangerous.

At least some people realize that:

Alzheimer's drug aducanumab not approved for use in EU - BBC News

 

[theeedude]

Science | AAAS

www.science.org

Looks like research behind the entire premise behind these drugs that plaques case Alzheimer's might have been doctored.

Two decades of Alzheimer’s research was based on deliberate fraud by 2 scientists that has cost billions of dollars and mi

Last month, drug company Genentech reported on the first clinical trials of the drug crenezumab, a drug targeting amyloid proteins that form

wallstreetpro.com

 

[hal2kilo]

Science | AAAS

www.science.org

Looks like research behind the entire premise behind these drugs that plaques case Alzheimer's might have been doctored.

Two decades of Alzheimer’s research was based on deliberate fraud by 2 scientists that has cost billions of dollars and mi

Last month, drug company Genentech reported on the first clinical trials of the drug crenezumab, a drug targeting amyloid proteins that form

wallstreetpro.com

That article is deeply depressing.

 

[theeedude]

The fact that FDA approved a drug that would put a major strain on Medicare that shows no real world benefit and is based on decades of questionable science? Pretty much par for the course for failing American society with political and regulatory capture by elites for their own benefit.

 

[hal2kilo]

Looks like Biogen has walked away from further development. Apparently, it probably didn't really work. They are now working with on an already traditionally FDA approved drug Leqembi made by Eisai. Fast tracking failed in this case.

Biogen to cease production of controversial Alzheimer's drug

The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer's disease treatment.

www.politico.com

 

[uclaLabrat]

Really devestating that so much work, resources, etc. Were spent chasing a disease target thats so burdensome where the fundamental biological research was likely founded on extensive fraud.